K220999

Substantially Equivalent

Hipro Glycosylated Hemoglobin (HbA1c) Test System

Applicant: Shijiazhuang Hipro Biotechnology Co., Ltd.
Product code: PDJ
Advisory panel: Clinical Chemistry
Date received: 2022-04-04
Decision date: 2024-09-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Shijiazhuang, CN

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.